Home/ Supplements/ Feverfew/ Feverfew

Feverfew

product on market Capsule Vitabase Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Feverfew
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 380.0mg (120 products) 8 studies — no high-quality reviews

Other Ingredients

Gelatin May contain one or more of the following:
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, adults take one (1) capsule daily at meal time, or as directed by a health care professional.

Warnings & Precautions

Keep out of reach of children.

Formulation Notes

Feverfew Standardized 350 mg 0.7% Parthenolide, 2.45 mg Per Capsule

Contains No Added sugar, salt, dairy, yeast, wheat, corn, soy, preservatives, artificial colors or flavors.

Additional Information

Vb

Our Feverfew is grown organically in the rich soil of Galilean farmlands in Israel. In this region its growth is carefully monitored through a unique state-of-the-art cultivation technology to ensure the leaves contain the highest concentration of naturally occurring parthenolide. A standardized level of 0.7% Parthenolide is achieved without the use of harsh chemicals.

Vitabase uses only high quality ingredients.

QUALITY AND POTENCY GUARANTEED.

Store in a cool, dry place and away from direct light.

Metadata

Product Details

DSLD Entry Date2012-03-23
Product TypeBotanical
FormCapsule
DSLD ID7085
Data Updated2026-04-11
Research

Research Evidence

10
Research Sources
48
Avg Quality
4
Systematic Review
4
Rct
1
Meta Analysis
1
Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004 PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988 PubMed
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009 PubMed DOI
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006 PubMed
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012 PubMed DOI
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004 PubMed
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998 PubMed
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985 PubMed
View all evidence for Feverfew →
Compare

Similar Products

View all Feverfew products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.